| Year |
Citation |
Score |
| 2022 |
Arendash G, Abulaban H, Steen S, Andel R, Wang Y, Bai Y, Baranowski R, McGarity J, Scritsmier L, Lin X, Shen N, Aljassabi A, Li Y, Cao C. Transcranial Electromagnetic Treatment Stops Alzheimer's Disease Cognitive Decline over a 2½-Year Period: A Pilot Study. Medicines (Basel, Switzerland). 9. PMID 36005647 DOI: 10.3390/medicines9080042 |
0.311 |
|
| 2019 |
Arendash G, Cao C, Abulaban H, Baranowski R, Wisniewski G, Becerra L, Andel R, Lin X, Zhang X, Wittwer D, Moulton J, Arrington J, Smith A. A Clinical Trial of Transcranial Electromagnetic Treatment in Alzheimer's Disease: Cognitive Enhancement and Associated Changes in Cerebrospinal Fluid, Blood, and Brain Imaging. Journal of Alzheimer's Disease : Jad. PMID 31403948 DOI: 10.3233/Jad-190367 |
0.454 |
|
| 2016 |
Arendash GW. Review of the Evidence that Transcranial Electromagnetic Treatment will be a Safe and Effective Therapeutic Against Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 27258417 DOI: 10.3233/Jad-160165 |
0.393 |
|
| 2015 |
Citron BA, Saykally JN, Cao C, Dennis JS, Runfeldt M, Arendash GW. Transcription factor Sp1 inhibition, memory, and cytokines in a mouse model of Alzheimer's disease. American Journal of Neurodegenerative Disease. 4: 40-8. PMID 26807343 |
0.322 |
|
| 2015 |
Citron BA, Saykally JN, Cao C, Dennis JS, Runfeldt M, Arendash GW. Transcription factor Sp1 inhibition, memory, and cytokines in a mouse model of alzheimer’s disease American Journal of Neurodegenerative Diseases. 4: 40-48. |
0.311 |
|
| 2013 |
Tajiri N, Kellogg SL, Shimizu T, Arendash GW, Borlongan CV. Traumatic brain injury precipitates cognitive impairment and extracellular Aβ aggregation in Alzheimer's disease transgenic mice. Plos One. 8: e78851. PMID 24223856 DOI: 10.1371/Journal.Pone.0078851 |
0.766 |
|
| 2012 |
Dragicevic N, Delic V, Cao C, Copes N, Lin X, Mamcarz M, Wang L, Arendash GW, Bradshaw PC. Caffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in Alzheimer's mice and cells. Neuropharmacology. 63: 1368-79. PMID 22959965 DOI: 10.1016/J.Neuropharm.2012.08.018 |
0.368 |
|
| 2012 |
Arendash GW. Transcranial electromagnetic treatment against Alzheimer's disease: why it has the potential to trump Alzheimer's disease drug development. Journal of Alzheimer's Disease : Jad. 32: 243-66. PMID 22810103 DOI: 10.3233/Jad-2012-120943 |
0.481 |
|
| 2012 |
Arendash GW, Mori T, Dorsey M, Gonzalez R, Tajiri N, Borlongan C. Electromagnetic treatment to old Alzheimer's mice reverses β-amyloid deposition, modifies cerebral blood flow, and provides selected cognitive benefit. Plos One. 7: e35751. PMID 22558216 DOI: 10.1371/Journal.Pone.0035751 |
0.474 |
|
| 2012 |
Cao C, Loewenstein DA, Lin X, Zhang C, Wang L, Duara R, Wu Y, Giannini A, Bai G, Cai J, Greig M, Schofield E, Ashok R, Small B, Potter H, ... Arendash GW, et al. High Blood caffeine levels in MCI linked to lack of progression to dementia. Journal of Alzheimer's Disease : Jad. 30: 559-72. PMID 22430531 DOI: 10.3233/Jad-2012-111781 |
0.331 |
|
| 2012 |
Mori T, Rezai-Zadeh K, Koyama N, Arendash GW, Yamaguchi H, Kakuda N, Horikoshi-Sakuraba Y, Tan J, Town T. Tannic acid is a natural β-secretase inhibitor that prevents cognitive impairment and mitigates Alzheimer-like pathology in transgenic mice. The Journal of Biological Chemistry. 287: 6912-27. PMID 22219198 DOI: 10.1074/Jbc.M111.294025 |
0.479 |
|
| 2012 |
O'Neal-Moffitt G, Arendash G, Mamcarz M, Olcese J. P3-329: Effects of melatonin on cytoskeletal and synaptic proteins in an Alzheimer's mouse model Alzheimer's & Dementia. 8: P573-P574. DOI: 10.1016/J.Jalz.2012.05.1553 |
0.305 |
|
| 2011 |
Zeitlin R, Patel S, Burgess S, Arendash GW, Echeverria V. Caffeine induces beneficial changes in PKA signaling and JNK and ERK activities in the striatum and cortex of Alzheimer's transgenic mice. Brain Research. 1417: 127-36. PMID 21907331 DOI: 10.1016/J.Brainres.2011.08.036 |
0.431 |
|
| 2011 |
Dragicevic N, Bradshaw PC, Mamcarz M, Lin X, Wang L, Cao C, Arendash GW. Long-term electromagnetic field treatment enhances brain mitochondrial function of both Alzheimer's transgenic mice and normal mice: A mechanism for electromagnetic field-induced cognitive benefit? Neuroscience. 185: 135-149. PMID 21514369 DOI: 10.1016/J.Neuroscience.2011.04.012 |
0.439 |
|
| 2011 |
Cao C, Wang L, Lin X, Mamcarz M, Zhang C, Bai G, Nong J, Sussman S, Arendash G. Caffeine synergizes with another coffee component to increase plasma GCSF: linkage to cognitive benefits in Alzheimer's mice. Journal of Alzheimer's Disease : Jad. 25: 323-35. PMID 21422521 DOI: 10.3233/Jad-2011-110110 |
0.435 |
|
| 2011 |
Dragicevic N, Copes N, O'Neal-Moffitt G, Jin J, Buzzeo R, Mamcarz M, Tan J, Cao C, Olcese JM, Arendash GW, Bradshaw PC. Melatonin treatment restores mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling. Journal of Pineal Research. 51: 75-86. PMID 21355879 DOI: 10.1111/J.1600-079X.2011.00864.X |
0.415 |
|
| 2011 |
Echeverria V, Zeitlin R, Burgess S, Patel S, Barman A, Thakur G, Mamcarz M, Wang L, Sattelle DB, Kirschner DA, Mori T, Leblanc RM, Prabhakar R, Arendash GW. Cotinine reduces amyloid-β aggregation and improves memory in Alzheimer's disease mice. Journal of Alzheimer's Disease : Jad. 24: 817-35. PMID 21321389 DOI: 10.3233/Jad-2011-102136 |
0.424 |
|
| 2010 |
Casadesus G, Arendash G, Laferla F, McDonald M. Animal models of Alzheimer's disease. International Journal of Alzheimer's Disease. 2010: 606357. PMID 21804934 DOI: 10.4061/2010/606357 |
0.406 |
|
| 2010 |
Boyd TD, Bennett SP, Mori T, Governatori N, Runfeldt M, Norden M, Padmanabhan J, Neame P, Wefes I, Sanchez-Ramos J, Arendash GW, Potter H. GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice. Journal of Alzheimer's Disease : Jad. 21: 507-18. PMID 20555144 DOI: 10.3233/Jad-2010-091471 |
0.445 |
|
| 2010 |
Dragicevic N, Mamcarz M, Zhu Y, Buzzeo R, Tan J, Arendash GW, Bradshaw PC. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice. Journal of Alzheimer's Disease : Jad. 20: S535-50. PMID 20463404 DOI: 10.3233/Jad-2010-100342 |
0.391 |
|
| 2010 |
Arendash GW, Cao C. Caffeine and coffee as therapeutics against Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 20: S117-26. PMID 20182037 DOI: 10.3233/Jad-2010-091249 |
0.493 |
|
| 2010 |
Arendash GW, Sanchez-Ramos J, Mori T, Mamcarz M, Lin X, Runfeldt M, Wang L, Zhang G, Sava V, Tan J, Cao C. Electromagnetic field treatment protects against and reverses cognitive impairment in Alzheimer's disease mice. Journal of Alzheimer's Disease : Jad. 19: 191-210. PMID 20061638 DOI: 10.3233/Jad-2010-1228 |
0.473 |
|
| 2010 |
Mori T, Koyama N, Arendash GW, Horikoshi-Sakuraba Y, Tan J, Town T. Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease. Glia. 58: 300-14. PMID 19705461 DOI: 10.1002/Glia.20924 |
0.46 |
|
| 2009 |
Cao C, Cirrito JR, Lin X, Wang L, Wang L, Verges DK, Dickson A, Mamcarz M, Zhang C, Mori T, Arendash GW, Holtzman DM, Potter H. Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice. Journal of Alzheimer's Disease : Jad. 17: 681-97. PMID 19581723 DOI: 10.3233/Jad-2009-1071 |
0.458 |
|
| 2009 |
Arendash GW, Mori T, Cao C, Mamcarz M, Runfeldt M, Dickson A, Rezai-Zadeh K, Tane J, Citron BA, Lin X, Echeverria V, Potter H. Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice. Journal of Alzheimer's Disease : Jad. 17: 661-80. PMID 19581722 DOI: 10.3233/Jad-2009-1087 |
0.512 |
|
| 2009 |
Arendash GW, Cox AA, Mori T, Cracchiolo JR, Hensley KL, Roberts LJ. Oxygen treatment triggers cognitive impairment in Alzheimer's transgenic mice. Neuroreport. 20: 1087-92. PMID 19543132 DOI: 10.1097/Wnr.0B013E32832E6459 |
0.465 |
|
| 2009 |
Olcese JM, Cao C, Mori T, Mamcarz MB, Maxwell A, Runfeldt MJ, Wang L, Zhang C, Lin X, Zhang G, Arendash GW. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. Journal of Pineal Research. 47: 82-96. PMID 19538338 DOI: 10.1111/J.1600-079X.2009.00692.X |
0.497 |
|
| 2009 |
Sanchez-Ramos J, Song S, Sava V, Catlow B, Lin X, Mori T, Cao C, Arendash GW. Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice. Neuroscience. 163: 55-72. PMID 19500657 DOI: 10.1016/J.Neuroscience.2009.05.071 |
0.426 |
|
| 2009 |
Echeverria V, Burgess S, Gamble-George J, Zeitlin R, Lin X, Cao C, Arendash GW. Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice. Neuroscience. 162: 1220-31. PMID 19447162 DOI: 10.1016/J.Neuroscience.2009.05.019 |
0.446 |
|
| 2009 |
Cao C, Arendash GW, Dickson A, Mamcarz MB, Lin X, Ethell DW. Abeta-specific Th2 cells provide cognitive and pathological benefits to Alzheimer's mice without infiltrating the CNS. Neurobiology of Disease. 34: 63-70. PMID 19167499 DOI: 10.1016/J.Nbd.2008.12.015 |
0.439 |
|
| 2009 |
Catlow BJ, Rowe AR, Clearwater CR, Mamcarz M, Arendash GW, Sanchez-Ramos J. Effects of environmental enrichment and physical activity on neurogenesis in transgenic PS1/APP mice. Brain Research. 1256: 173-9. PMID 19135431 DOI: 10.1016/J.Brainres.2008.12.028 |
0.413 |
|
| 2009 |
Ethell DW, Cao C, Dickson A, Mamcarz MB, Lin X, Arendash GW. P3-262: Cognitive and pathological benefits of Aβ-sensitive Th2 cells are independent of Antigen-Specific B cell activation Alzheimer's & Dementia. 5: P420-P420. DOI: 10.1016/J.Jalz.2009.04.933 |
0.311 |
|
| 2008 |
Sanchez-Ramos J, Song S, Cao C, Arendash G. The potential of hematopoietic growth factors for treatment of Alzheimer's disease: a mini-review. Bmc Neuroscience. 9: S3. PMID 19090991 DOI: 10.1186/1471-2202-9-S2-S3 |
0.3 |
|
| 2008 |
Echeverria V, Burgess S, Gamble-George J, Arendash GW, Citron BA. Raf inhibition protects cortical cells against beta-amyloid toxicity. Neuroscience Letters. 444: 92-6. PMID 18706973 DOI: 10.1016/J.Neulet.2008.07.092 |
0.422 |
|
| 2008 |
Rezai-Zadeh K, Arendash GW, Hou H, Fernandez F, Jensen M, Runfeldt M, Shytle RD, Tan J. Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Research. 1214: 177-87. PMID 18457818 DOI: 10.1016/J.Brainres.2008.02.107 |
0.701 |
|
| 2008 |
Mori T, Tan J, Arendash GW, Koyama N, Nojima Y, Town T. Overexpression of human S100B exacerbates brain damage and periinfarct gliosis after permanent focal ischemia. Stroke; a Journal of Cerebral Circulation. 39: 2114-21. PMID 18451356 DOI: 10.1161/Strokeaha.107.503821 |
0.379 |
|
| 2008 |
Leighty RE, Runfeldt MJ, Berndt DJ, Schleif WS, Cracchiolo JR, Potter H, Arendash GW. Use of artificial neural networks to determine cognitive impairment and therapeutic effectiveness in Alzheimer's transgenic mice. Journal of Neuroscience Methods. 167: 358-66. PMID 17904642 DOI: 10.1016/J.Jneumeth.2007.08.008 |
0.446 |
|
| 2008 |
Arendash GW, Mamcarz M, Dickson A, Wang L, Xiaoyang L, Cao C, Potter H. P1-068: Environmental enrichment “sessions” are sufficient to provide cognitive benefit to impaired Alzheimer's transgenic mice without affecting brain or plasma Aβ levels Alzheimer's & Dementia. 4: T226-T226. DOI: 10.1016/J.Jalz.2008.05.654 |
0.455 |
|
| 2008 |
Ethell DW, Cao C, Dickson A, Mamcarz MB, Lin X, Arendash GW. O3-05-08: Amyloid-β-responsive Th2 cells reduce microglial activation, reduce serum cytokines, increase plasma amyloid-β, and improve hippocampal-dependent memory in APP+PS1 mice Alzheimer's & Dementia. 4: T170-T170. DOI: 10.1016/J.Jalz.2008.05.448 |
0.343 |
|
| 2008 |
Arendash GW, Cao C, Mori T, Mamcartz M, Dickson A, Wang L, Runfelt M, Rezai-zadeh K, Tan J, Xiaoyang L, Potter H. O1-04-04: Caffeine reverses cognitive impairment, decreases β-amyloid levels, and reduces inflammation in aged Alzheimer's mice: Implications for Alzheimer's treatment Alzheimer's & Dementia. 4: T115-T115. DOI: 10.1016/J.Jalz.2008.05.241 |
0.437 |
|
| 2008 |
Moran VE, Gamble-George J, Burgess S, Dickson A, Mamcarz M, Arendash GW. P4-303: Sorafenib as a therapeutic agent against Alzheimer's disease Alzheimer's & Dementia. 4: T760-T760. DOI: 10.1016/J.Jalz.2008.05.2373 |
0.309 |
|
| 2008 |
Sanchez-Ramos J, Song S, Cao C, Lin X, Mori T, Arendash G. P2-309: Granulocyte-colony simulating factor reduces hippocampal amyloid load and improves behavioral performance in a transgenic Alzheimer's disease mouse model Alzheimer's & Dementia. 4: T463-T463. DOI: 10.1016/J.Jalz.2008.05.1386 |
0.363 |
|
| 2008 |
Cao C, Lin X, Zhang C, Dickson A, Mamcarz M, Wang L, Arendash G, Potter H. IC-P3-174: Plasma Aβ level can be used as marker for AD treatment in PS1/APP Alzheimer's mouse model Alzheimer's & Dementia. 4: T77-T77. DOI: 10.1016/J.Jalz.2008.05.118 |
0.317 |
|
| 2007 |
Arendash GW, Jensen MT, Salem N, Hussein N, Cracchiolo J, Dickson A, Leighty R, Potter H. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice. Neuroscience. 149: 286-302. PMID 17904756 DOI: 10.1016/J.Neuroscience.2007.08.018 |
0.661 |
|
| 2007 |
Cracchiolo JR, Mori T, Nazian SJ, Tan J, Potter H, Arendash GW. Enhanced cognitive activity--over and above social or physical activity--is required to protect Alzheimer's mice against cognitive impairment, reduce Abeta deposition, and increase synaptic immunoreactivity. Neurobiology of Learning and Memory. 88: 277-94. PMID 17714960 DOI: 10.1016/J.Nlm.2007.07.007 |
0.417 |
|
| 2007 |
Suo Z, Cox AA, Bartelli N, Rasul I, Festoff BW, Premont RT, Arendash GW. GRK5 deficiency leads to early Alzheimer-like pathology and working memory impairment. Neurobiology of Aging. 28: 1873-88. PMID 17011668 DOI: 10.1016/J.Neurobiolaging.2006.08.013 |
0.426 |
|
| 2007 |
Costa DA, Cracchiolo JR, Bachstetter AD, Hughes TF, Bales KR, Paul SM, Mervis RF, Arendash GW, Potter H. Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms. Neurobiology of Aging. 28: 831-44. PMID 16730391 DOI: 10.1016/J.Neurobiolaging.2006.04.009 |
0.471 |
|
| 2007 |
Arendash GW, Rezai-Zadeh K, Cao C, Mamcarz M, Dickson A, Schleif W, Runfeldt M, Lin X, Cracchiolo J, Shippy D, Raj A, Tan J, Potter H. O1-01-01: Caffeine: Evidence for protection against, and treatment for, Alzheimer's disease by direct suppression of disease pathogenesis Alzheimer's & Dementia. 3: S166-S166. DOI: 10.1016/J.Jalz.2007.04.355 |
0.306 |
|
| 2007 |
Suo Z, Bartelli N, Rasul I, Wu G, Li L, Premont RT, Arendash GW. P-133: GRK5 deficient mouse is a novel model for early Alzheimer's disease Alzheimer's & Dementia. 3: S141-S141. DOI: 10.1016/J.Jalz.2007.04.197 |
0.339 |
|
| 2006 |
Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, Cracchiolo JR, Shippy D, Tan J. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production. Neuroscience. 142: 941-52. PMID 16938404 DOI: 10.1016/J.Neuroscience.2006.07.021 |
0.503 |
|
| 2006 |
Ethell DW, Shippy D, Cao C, Cracchiolo JR, Runfeldt M, Blake B, Arendash GW. Abeta-specific T-cells reverse cognitive decline and synaptic loss in Alzheimer's mice. Neurobiology of Disease. 23: 351-61. PMID 16733088 DOI: 10.1016/J.Nbd.2006.03.008 |
0.42 |
|
| 2006 |
Obregon DF, Rezai-Zadeh K, Bai Y, Sun N, Hou H, Ehrhart J, Zeng J, Mori T, Arendash GW, Shytle D, Town T, Tan J. ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein. The Journal of Biological Chemistry. 281: 16419-27. PMID 16624814 DOI: 10.1074/Jbc.M600617200 |
0.326 |
|
| 2005 |
Jensen MT, Mottin MD, Cracchiolo JR, Leighty RE, Arendash GW. Lifelong immunization with human beta-amyloid (1-42) protects Alzheimer's transgenic mice against cognitive impairment throughout aging. Neuroscience. 130: 667-84. PMID 15590151 DOI: 10.1016/J.Neuroscience.2004.09.055 |
0.68 |
|
| 2005 |
Potter H, Costa DA, Cracciola JR, Hughes T, Arendash GW. [O2-03-02]: Environmental enrichment prevents cognitive decline and induces memory-related gene expression in a mouse model of Alzheimer's disease Alzheimer's & Dementia. 1: S99-S99. DOI: 10.1016/J.Jalz.2005.06.343 |
0.364 |
|
| 2004 |
Bjugstad KB, Flitter WD, Arendash GW. Intracerebroventricular infusions of gp120 inhibit weight gain and induce atrophy in the hippocampus and neostriatum without affecting cognition. Journal of Neuro-Aids. 2: 15-31. PMID 16873203 DOI: 10.1300/J128v02n04_02 |
0.61 |
|
| 2004 |
Nilsson LN, Arendash GW, Leighty RE, Costa DA, Low MA, Garcia MF, Cracciolo JR, Rojiani A, Wu X, Bales KR, Paul SM, Potter H. Cognitive impairment in PDAPP mice depends on ApoE and ACT-catalyzed amyloid formation. Neurobiology of Aging. 25: 1153-67. PMID 15312961 DOI: 10.1016/J.Neurobiolaging.2003.12.011 |
0.475 |
|
| 2004 |
Arendash GW, Garcia MF, Costa DA, Cracchiolo JR, Wefes IM, Potter H. Environmental enrichment improves cognition in aged Alzheimer's transgenic mice despite stable beta-amyloid deposition. Neuroreport. 15: 1751-4. PMID 15257141 DOI: 10.1097/01.Wnr.0000137183.68847.4E |
0.471 |
|
| 2004 |
Leighty RE, Nilsson LN, Potter H, Costa DA, Low MA, Bales KR, Paul SM, Arendash GW. Use of multimetric statistical analysis to characterize and discriminate between the performance of four Alzheimer's transgenic mouse lines differing in Abeta deposition. Behavioural Brain Research. 153: 107-21. PMID 15219712 DOI: 10.1016/J.Bbr.2003.11.004 |
0.413 |
|
| 2004 |
Arendash GW, Lewis J, Leighty RE, McGowan E, Cracchiolo JR, Hutton M, Garcia MF. Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's disease: linkage of poorer cognitive performance to tau pathology in forebrain. Brain Research. 1012: 29-41. PMID 15158158 DOI: 10.1016/J.Brainres.2004.02.081 |
0.46 |
|
| 2003 |
Austin L, Arendash GW, Gordon MN, Diamond DM, DiCarlo G, Dickey C, Ugen K, Morgan D. Short-term beta-amyloid vaccinations do not improve cognitive performance in cognitively impaired APP + PS1 mice. Behavioral Neuroscience. 117: 478-84. PMID 12802876 DOI: 10.1037/0735-7044.117.3.478 |
0.441 |
|
| 2003 |
Joseph JA, Denisova NA, Arendash G, Gordon M, Diamond D, Shukitt-Hale B, Morgan D. Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutritional Neuroscience. 6: 153-62. PMID 12793519 DOI: 10.1080/1028415031000111282 |
0.39 |
|
| 2002 |
Arendash GW, King DL. Intra- and intertask relationships in a behavioral test battery given to Tg2576 transgenic mice and controls. Physiology & Behavior. 75: 643-52. PMID 12020729 DOI: 10.1016/S0031-9384(02)00640-6 |
0.388 |
|
| 2002 |
King DL, Arendash GW. Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months. Physiology & Behavior. 75: 627-42. PMID 12020728 DOI: 10.1016/S0031-9384(02)00639-X |
0.433 |
|
| 2002 |
King DL, Arendash GW. Maintained synaptophysin immunoreactivity in Tg2576 transgenic mice during aging: correlations with cognitive impairment. Brain Research. 926: 58-68. PMID 11814407 DOI: 10.1016/S0006-8993(01)03294-2 |
0.435 |
|
| 2001 |
Arendash GW, Gordon MN, Diamond DM, Austin LA, Hatcher JM, Jantzen P, DiCarlo G, Wilcock D, Morgan D. Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory. Dna and Cell Biology. 20: 737-44. PMID 11788052 DOI: 10.1089/10445490152717604 |
0.404 |
|
| 2001 |
Gordon MN, King DL, Diamond DM, Jantzen PT, Boyett KV, Hope CE, Hatcher JM, DiCarlo G, Gottschall WP, Morgan D, Arendash GW. Correlation between cognitive deficits and Abeta deposits in transgenic APP+PS1 mice. Neurobiology of Aging. 22: 377-85. PMID 11378242 DOI: 10.1016/S0197-4580(00)00249-9 |
0.449 |
|
| 2001 |
Arendash GW, King DL, Gordon MN, Morgan D, Hatcher JM, Hope CE, Diamond DM. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Research. 891: 42-53. PMID 11164808 DOI: 10.1016/S0006-8993(00)03186-3 |
0.472 |
|
| 2001 |
Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope C, Gordon M, Arendash GW. Erratum: correction: Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease Nature. 412: 660-660. DOI: 10.1038/35088102 |
0.331 |
|
| 2000 |
Bjugstad KB, Flitter WD, Garland WA, Philpot RM, Kirstein CL, Arendash GW. CPI-1189 prevents apoptosis and reduces glial fibrillary acidic protein immunostaining in a TNF-alpha infusion model for AIDS dementia complex. Journal of Neurovirology. 6: 478-91. PMID 11175320 DOI: 10.3109/13550280009091948 |
0.624 |
|
| 2000 |
Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope C, Gordon M, Arendash GW. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature. 408: 982-5. PMID 11140686 DOI: 10.1038/35050116 |
0.409 |
|
| 2000 |
Morgan D, Gordon MN, Diamond D, King D, Arendash G. Age-related memory deficits in doubly transgenic mice correlate with amyloid burden Neurobiology of Aging. 21: 18. DOI: 10.1016/S0197-4580(00)82758-X |
0.383 |
|
| 1999 |
King DL, Arendash GW, Crawford F, Sterk T, Menendez J, Mullan MJ. Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease. Behavioural Brain Research. 103: 145-62. PMID 10513583 DOI: 10.1016/S0166-4328(99)00037-6 |
0.443 |
|
| 1999 |
Arendash GW, Su GC, Crawford FC, Bjugstad KB, Mullan M. Intravascular beta-amyloid infusion increases blood pressure: implications for a vasoactive role of beta-amyloid in the pathogenesis of Alzheimer's disease. Neuroscience Letters. 268: 17-20. PMID 10400067 DOI: 10.1016/S0304-3940(99)00239-6 |
0.642 |
|
| 1999 |
Linert W, Bridge MH, Huber M, Bjugstad KB, Grossman S, Arendash GW. In vitro and in vivo studies investigating possible antioxidant actions of nicotine: relevance to Parkinson's and Alzheimer's diseases. Biochimica Et Biophysica Acta. 1454: 143-52. PMID 10381559 DOI: 10.1016/S0925-4439(99)00029-0 |
0.658 |
|
| 1999 |
Pompl PN, Mullan MJ, Bjugstad K, Arendash GW. Adaptation of the circular platform spatial memory task for mice: use in detecting cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease. Journal of Neuroscience Methods. 87: 87-95. PMID 10065997 DOI: 10.1016/S0165-0270(98)00169-1 |
0.683 |
|
| 1999 |
Socci DJ, Bjugstad KB, Jones HC, Pattisapu JV, Arendash GW. Evidence that oxidative stress is associated with the pathophysiology of inherited hydrocephalus in the H-Tx rat model. Experimental Neurology. 155: 109-17. PMID 9918710 DOI: 10.1006/Exnr.1998.6969 |
0.643 |
|
| 1999 |
Su GC, Arendash GW, Kalaria RN, Bjugstad KB, Mullan M. Intravascular infusions of soluble beta-amyloid compromise the blood-brain barrier, activate CNS glial cells and induce peripheral hemorrhage. Brain Research. 818: 105-17. PMID 9914443 DOI: 10.1016/S0006-8993(98)01143-3 |
0.695 |
|
| 1998 |
Bjugstad KB, Flitter WD, Garland WA, Su GC, Arendash GW. Preventive actions of a synthetic antioxidant in a novel animal model of AIDS dementia Brain Research. 795: 349-357. PMID 9622673 DOI: 10.1016/S0006-8993(98)00351-5 |
0.651 |
|
| 1996 |
Borlongan CV, Bjugstad KB, Stahl CE, Ross SD, Arendash GW, Cahill DW, Sanberg PR. Age-dependent neurobehavioral responses by young and mature adult rats to systemic kainic acid. Restorative Neurology and Neuroscience. 10: 103-8. PMID 21551859 DOI: 10.3233/Rnn-1996-10206 |
0.636 |
|
| 1996 |
Socci DJ, Arendash GW. Chronic nicotine treatment prevents neuronal loss in neocortex resulting from nucleus basalis lesions in young adult and aged rats Molecular and Chemical Neuropathology. 27: 285-305. PMID 9147414 DOI: 10.1007/Bf02815110 |
0.329 |
|
| 1996 |
Sack CA, Socci DJ, Crandall BM, Arendash GW. Antioxidant treatment with phenyl-α-tert-butyl nitrone (PBN) improves the cognitive performance and survival of aging rats Neuroscience Letters. 205: 181-184. PMID 8852588 DOI: 10.1016/0304-3940(96)12417-4 |
0.391 |
|
| 1996 |
Bjugstad KB, Mahnir VM, Kem WR, Socci DJ, Arendash GW. Long-term treatment with GTS-21 or nicotine enhances water maze performance in aged rats without affecting the density of nicotinic receptor subtypes in neocortex Drug Development Research. 39: 19-28. DOI: 10.1002/(Sici)1098-2299(19960901)39:1<19::Aid-Ddr3>3.0.Co;2-N |
0.65 |
|
| 1995 |
Socci DJ, Crandall BM, Arendash GW. Chronic antioxidant treatment improves the cognitive performance of aged rats Brain Research. 693: 88-94. PMID 8653426 DOI: 10.1016/0006-8993(95)00707-W |
0.382 |
|
| 1995 |
Socci DJ, Sanberg PR, Arendash GW. Nicotine enhances morris water maze performance of young and aged rats Neurobiology of Aging. 16: 857-860. PMID 8532124 DOI: 10.1016/0197-4580(95)00091-R |
0.365 |
|
| 1995 |
Arendash GW, Sengstock GJ, Sanberg PR, Kem WR. Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21. Brain Research. 674: 252-9. PMID 7796104 DOI: 10.1016/0006-8993(94)01449-R |
0.375 |
|
| 1992 |
Sengstock GJ, Johnson KB, Jantzen PT, Meyer EM, Dunn AJ, Arendash GW. Nucleus basalis lesions in neonate rats induce a selective cortical cholinergic hypofunction and cognitive deficits during adulthood Experimental Brain Research. 90: 163-174. PMID 1521605 DOI: 10.1007/Bf00229268 |
0.346 |
|
| 1992 |
Zawia N, Arendash GW, Wecker L. Basal forebrain cholinergic neurons in aged rat brain are more susceptible to ibotenate-induced degeneration than neurons in young adult brain. Brain Research. 589: 333-7. PMID 1393599 DOI: 10.1016/0006-8993(92)91295-P |
0.33 |
|
| 1990 |
Mouton PR, Arendash GW. Atrophy of cholinergic neurons within the rat nucleus basalis magnocellularis following intracortical AF64A infusion Neuroscience Letters. 111: 52-57. PMID 2336191 DOI: 10.1016/0304-3940(90)90343-8 |
0.314 |
|
| 1989 |
Mouton PR, Meyer EM, Arendash GW. Intracortical AF64A: Memory impairments and recovery from cholinergic hypofunction Pharmacology, Biochemistry and Behavior. 32: 841-848. PMID 2798533 DOI: 10.1016/0091-3057(89)90045-2 |
0.344 |
|
| 1988 |
Mouton PR, Meyer EM, Dunn AJ, Millard W, Arendash GW. Induction of cortical cholinergic hypofunction and memory retention deficits through intracortical AF64A infusions Brain Research. 444: 104-118. PMID 3359282 DOI: 10.1016/0006-8993(88)90918-3 |
0.316 |
|
| 1987 |
Arendash GW, Millard WJ, Dunn AJ, Meyer EM. Long-term neuropathological and neurochemical effects of nucleus basalis lesions in the rat. Science (New York, N.Y.). 238: 952-6. PMID 2890210 DOI: 10.1126/Science.2890210 |
0.335 |
|
| Show low-probability matches. |